IP Library Granted Patent US 8,258,279
Granted Patent B2
US 8,258,279 · App. 12/236,806 · Granted Sep 4, 2012

Isolated nucleic acids encoding soluble corticotropin releasing factor receptor type 2 (sCRFR2) polypeptides

Assignee: Research Development Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,258,279
App. No.
12/236,806
Granted
Sep 4, 2012
Kind
B2
Abstract

The present invention is directed to compositions and methods related to soluble G-protein coupled receptors (sGPCR). In certain aspects the invention includes compositions and methods related to a soluble corticotropin releasing factor receptor related protein, sCRFR2, as well as its effects on CRFR signaling and interaction between CRF family ligand and CRFR receptors, including but not limited to CRFR2, CRFR1 and functional or signaling capable variants thereof.

Claims (12)

1. An isolated nucleic acid encoding a soluble corticotropin releasing factor receptor type 2 polypeptide (sCRFR2) having an amino acid sequence that is at least 95% identical to SEQ ID NO:4 or SEQ ID NO:15.

2. The nucleic acid of claim 1 , further comprising a promoter operably coupled to the nucleic acid encoding the sCRFR2.

3. The nucleic acid of claim 2 , wherein the nucleic acid is an expression cassette.

4. The nucleic acid of claim 3 , wherein the expression cassette is comprised in an expression vector.

5. The nucleic acid of claim 4 , wherein the expression vector is a linear nucleic acid, a plasmid expression vector, or a viral expression vector.

6. The nucleic acid of claim 4 , wherein the expression vector is operably coupled to a delivery vector.

7. The nucleic acid of claim 6 , wherein the delivery vector is a liposome, a polypeptide, a polycation, a lipid, a bacterium, or a virus.

8. The nucleic acid of claim 1 , further comprising a nucleic acid segment encoding an immunoglobulin constant region.

9. The nucleic acid of claim 1 , further defined as encoding a polypeptide that is at least 98% identical to SEQ ID NO:4.

10. The nucleic acid of claim 9 , further defined as encoding a polypeptide that comprises SEQ ID NO:4.

11. The nucleic acid of claim 1 , further defined as encoding a polypeptide that is at least 98% identical to SEQ ID NO:15.

12. The nucleic acid of claim 10 , further defined as encoding a polypeptide that comprises SEQ ID NO:15.

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 17, 2017
From: SALK INSTITUTE FOR BIOLOGICAL STUDIES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041746/0984 →
Continuity (3)
Division 11350411 · Feb 8, 2006
Provisional Application 60650866 · Feb 8, 2005
Related Publication 20090117649A1 · May 7, 2009